Streetbeat News

Stock Prices

ELUT

Elutia (NASDAQ:ELUT) reported Q3 earnings with an EPS of $(0.50), surpassing the $(0.54) estimate, marking a 31.51% improvement from last year. However, sales of $6.13M fell short of the $7.30M estimate, a significant 50.54% drop from the previous year.

Portfolio Pulse from mahesh@benzinga.com

November 13, 2023 | 9:16 pm

SKIN

Beauty Health (NASDAQ:SKIN) reported a significant Q3 EPS loss of $(0.56), which was a miss against the $0.09 estimate, marking a 722.22% miss and a 1220% decrease from the $0.05 per share earned in the same period last year. Sales were $97.40M, also missing the $116.30M estimate by 16.25%, despite being a 9.69% increase from the previous year's sales of $88.79M.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:16 pm

XGN

Exagen Inc. (NASDAQ:XGN) reported Q3 2023 earnings with a GAAP EPS of $(0.31), surpassing the $(0.46) estimate by 32.61%. Year-over-year, this represents a 34.04% improvement in EPS. Quarterly sales reached $13.42M, exceeding estimates by 29.87% but reflecting an 8.90% decrease from the previous year's same quarter.

Portfolio Pulse from saritha@benzinga.com

November 13, 2023 | 9:15 pm

NVTA

Piper Sandler analyst David Westenberg has maintained an Underweight rating on Invitae (NYSE:NVTA) and reduced the price target from $0.4 to $0.3.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:15 pm

WULF

TeraWulf reported Q3 2023 earnings per share (EPS) of $(0.09), which is an improvement from the estimated $(0.32). However, their revenue of $19M fell short of the estimated $19.692M.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:15 pm

HROW

Harrow (NASDAQ:HROW) reported Q3 earnings with an EPS of $-0.09, missing the estimated $0.04 by 325%. Revenue increased by $11.44 million from the same period last year. In the previous quarter, HROW beat EPS estimates but experienced a 15.45% share price drop the following day.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:15 pm

DRRX

Durect Corporation (NASDAQ:DRRX) reported Q3 earnings with an EPS of $-0.14, beating the estimate of $-0.42 by 66.67%. However, revenue decreased by $10.23 million compared to the same period last year. In the previous quarter, a beat on EPS estimates resulted in a 2.85% share price increase the following day.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:15 pm

LICY

Li-Cycle Holdings (NYSE:LICY) reported Q3 earnings with an EPS of $-0.19, beating estimates by 20.83% against an expected $-0.24. Revenue increased by $6.67 million compared to the same period last year. Despite beating this quarter, the company's share price dropped 5.67% the day after last quarter's earnings miss. Historical earnings show mixed results with misses and hits in previous quarters.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:15 pm

SMTI

Sanara MedTech reported a narrower Q3 loss of $(0.13) per share compared to $(0.18) YoY, but missed sales estimates with $16.02M versus the expected $18.80M. Despite the miss, sales increased by 22.81% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 9:15 pm

DRRX

Durect Corporation (NASDAQ:DRRX) reported Q3 2023 earnings with a GAAP EPS of $(0.14), surpassing the $(0.42) estimate, marking a significant beat by 66.67%. However, the company experienced a decline in earnings compared to the previous year, with losses increasing by 40% from $(0.10) per share. Sales for the quarter were $1.74M, falling short of the $2.97M estimate by 41.28% and representing an 85.44% decrease from the $11.98M reported in the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 13, 2023 | 9:14 pm